Network to Understand Reproductive Rheumatology Registry
NCT06940869 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-05-07
Summary
The purpose of the NURTURE Registry is to enroll those who are pregnant and/or potentially capable of pregnancy. Participants will complete patient-reported surveys at enrollment and periodically prior to conception, during pregnancy, and following the completion of the study pregnancy. The study rheumatologist will provide the patient's diagnosis and record rheumatic disease activity at each clinic visit. Medication use, vital signs, and routine laboratory assessments will be collected throughout this period. Pregnancy, maternal, and infant outcomes will be obtained through the electronic medical record and from patient-reported surveys. This Registry will provide a rich data repository for research to improve pregnancy and birth outcomes for women with rheumatic diseases and will be used in on-going and future research to better understand the risk factors that are associated with poor pregnancy outcomes, including preterm birth, intrauterine growth restriction, and preeclampsia, as well as the effects of medication on disease management in pregnancy. Infant outcomes, medications, provider care, pregnancy planning, and social determinants of health on pregnancy and pregnancy outcomes will also be collected.
The majority of the information collected in NURTURE, such as labs, disease activity, and medications, PRO's will originate from the EHR. Upon consent, participants will complete an enrollment survey that will include relevant patient reported measures. No study visits outside of routine care will occur. Participants may also complete a yearly survey about their reproductive health journey.
The registry will be ongoing and will include periodic analysis of clinical data within this protocol. Additional analysis will be covered under seperate IRB approved protocols. Enrollment in the registry does not significantly increase the risk for a patient.
Conditions
- Rheumatic Diseases
- Pregnancy Related
- Pregnancy Interest
- Reproductive Health
- Autoimmune Diseases
Interventions
- OTHER
-
NURTURE Registry
To improve pregnancy and birth outcomes for women with rheumatic diseases and to understand risk factors associated with poor pregnancy outcomes.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Megan Clowse · Professor of Medicine, Duke University Health System
Eligibility
- Min Age
- 12 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-19
- Primary Completion
- 2035-01-01
- Completion
- 2035-01-01
Countries
- United States
Study Locations
More Related Trials
-
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
NCT00121056 ·Status: COMPLETED
-
Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis
NCT03843619 ·Status: UNKNOWN
-
OTIS Humira Pregnancy Registry
NCT01086059 ·Status: COMPLETED
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 ·Status: RECRUITING
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
An Observational Study on Sarilumab-exposed Pregnancies
NCT03378219 ·Status: COMPLETED
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Hanyang University Medical Center Arthritis Network
NCT00418405 ·Status: UNKNOWN
-
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309 ·Status: WITHDRAWN
-
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
NCT01948388 ·Status: COMPLETED ·Phase: PHASE4
-
Cystatin D Fibrinogen Like Protein 1
NCT05929989 ·Status: NOT_YET_RECRUITING
-
Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis
NCT00209859 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Features and Pregnancy Outcomes of RA Patients
NCT05651373 ·Status: UNKNOWN
-
Fibrocytes in Early and Longstanding Rheumatoid Arthritis
NCT02652299 ·Status: COMPLETED
-
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
NCT04679272 ·Status: COMPLETED
-
Clinnova-RD: A Prospective Cohort Study of Patients With Rheumatoid Diseases
NCT06235684 ·Status: NOT_YET_RECRUITING
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
NCT03492658 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
NCT01111357 ·Status: COMPLETED
-
Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone
NCT00579644 ·Status: COMPLETED ·Phase: PHASE3
-
Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases
NCT04353609 ·Status: COMPLETED
-
Early Rheumatoid Arthritis COR Intervention
NCT02246257 ·Status: UNKNOWN ·Phase: NA
-
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
NCT00055055 ·Status: COMPLETED